Pediatric Psoriasis: Infection Risk Low With Systemic Meds
The results are from a large cohort study that estimated the 6-month rate of infections among children with psoriasis who started treatment with ustekinumab, etanercept, or methotrexate.
MDedge News
source https://www.medscape.com/viewarticle/988361?src=rss
MDedge News
source https://www.medscape.com/viewarticle/988361?src=rss
Comments
Post a Comment